Deal Dispatch: Abbott, TPG, Lonza Make Major Moves; M&M Custard & New Fortress Energy Struggle - Abbott Laboratories ( NYSE:ABT ) , Comcast ( NASDAQ:CMCSA )
Swiss life sciences giant Lonza Group is shopping its capsules and health ingredients division, and the shortlist is full of private equity heavy-hitters. In the running: Altaris, Lone Star Funds, and One Rock Capital. Expected sale price: At least €2.5 billion ( US$2.8 billion ) .
Cathie Wood Dumps AMD Shares, Loads Up On Nvidia With $17 Million Buy Amid Earnings Buzz: Ark Scoops Up These Crypto Stocks As Bitcoin, Ethereum Crash - Advanced Micro Devices ( NASDAQ:AMD )
On Thursday, Cathie Wood-led Ark Invest executed significant trades, including buying shares of Nvidia Corp ( NASDAQ:NVDA ) and selling shares of Advanced Micro Devices Inc. ( NASDAQ:AMD ) .
Biggest Stock Movers Today, Nov. 20: PACS, BBWI, & More
On a big day for tech stocks, some other less well-known companies saw even larger moves.
Why Exact Sciences Rallied Over 50% This Week
The company received a buyout offer from Abbot Labs.
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Exact Sciences Corporation ( Nasdaq - EXAS )
BALA CYNWYD, Pa., Nov. 20, 2025 ( GLOBE NEWSWIRE ) -- Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Exact Sciences Corporation ( "Exact Sciences" or the "Company" ) ( Nasdaq - EXAS ) for possible breaches of fiduciary duty and ...
Why Exact Sciences Stock Surged Today
A healthcare giant covets the cancer screening leader's technology.
Nutex Health Posts Strong Q3 Results, Joins PACS Group, Walmart, Cerence And Other Big Stocks Moving Higher On Thursday - Cipher Mining ( NASDAQ:CIFR ) , Aduro Clean Technologies ( NASDAQ:ADUR )
U.S. stocks were higher, with the Dow Jones gaining more than 250 points on Thursday. Shares of Nutex Health Inc ( NASDAQ:NUTX ) rose sharply during Thursday's session after the company reported better-than-expected third-quarter financial results.
Abbott's $21 Billion Exact Sciences Buyout Reshapes Cancer Diagnostics - Abbott Laboratories ( NYSE:ABT ) , Exact Sciences ( NASDAQ:EXAS )
Abbott Laboratories ( NYSE:ABT ) agreed on Thursday to acquire cancer screening company Exact Sciences Corp ( NASDAQ:EXAS ) for $105 per common share, representing a total equity value of approximately $21 billion and an estimated enterprise value of $23 billion.
Why Exact Sciences Stock Blasted Nearly 24% Higher Today
A strategic investor is reportedly in advanced talks to purchase the company.
Molina Secures Deal From AHCA to Serve Florida's Medicaid Members
MOH wins sole contract from AHCA to manage care for around 120,000 Florida enrollees of SMMC and CHIP through a Medicaid deal.
TEM Continues to Strengthen Its Genomics Leadership With New Products
Tempus AI advances its genomics push with new assays, CDx progress and plans for whole-genome sequencing to drive future growth.
MDxHealth ( MDXH ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Wednesday, Nov. 12, 2025 at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email [email protected] reading ...
Ensign Group Shares Decline 2.2% Despite Q3 Earnings Beat
ENSG shares slip 2.2% despite Q3 earnings and revenues topping estimates, as higher service and rent costs weigh on results.
Cathie Wood Dumps $30 Million Worth Of Tesla Stock Amid China Sales Slump, Loads Up Circle And This Hot Chinese AI Stock - Tesla ( NASDAQ:TSLA )
On Wednesday, Cathie Wood-led Ark Invest executed significant trades involving Circle Internet Group Inc. ( NYSE:CRCL ) , Alibaba Group Holding Ltd. ( NYSE:BABA ) , and Tesla Inc. ( NASDAQ:TSLA ) . These trades reflect Ark's strategic positioning in the market, with notable buys in Circle and ...
RGTI Stock Down Despite Q3 Earnings Top Estimates, Revenues Decline Y/Y
Rigetti's Q3 loss is narrower than estimates, but revenues decline as government contract delays hit sales and lower the gross margin.
Cathie Wood Goes Big On Alibaba With $25 Million Share Purchase, Scales Back On This Social Media Stock - Alibaba Gr Hldgs ( NYSE:BABA )
On Tuesday, Cathie Wood-led Ark Invest made significant moves in its portfolio, focusing on Alibaba Group Holding Ltd. ( NASDAQ:BABA ) , Baidu Inc. ( NASDAQ:BIDU ) , and Reddit Inc. ( NYSE:RDDT ) . These trades come amid a backdrop of evolving market dynamics and regulatory challenges, ...
Encompass Health Shares Down 8% Despite Q3 Earnings & Revenue Beat
EHC shares fall 8% after Q3 results, as higher costs offset revenue gains, bed expansions and an upbeat 2025 outlook.
Tenet Healthcare Shares Down 5% Despite Q3 Earnings Beat
THC's Q3 profit beats estimates on higher revenues and strong segment growth, but rising costs drag shares lower.
Is Exact Sciences ( EXAS ) Stock Outpacing Its Medical Peers This Year?
Here is how Exact Sciences (EXAS) and Amylyx Pharmaceuticals, Inc. (AMLX) have performed compared to their sector so far this year.
2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term
These companies are slowly coming into their own.
AMN Stock Gains Following Q3 Earnings & Revenue Beat, Margins Down
AMN Healthcare beats third-quarter 2025 earnings and revenue estimates despite lower margins and year-over-year declines across key segments.
Doximity Stock Down Despite Q2 Earnings Beat, Revenues Up Y/Y
DOCS Q2 results benefit from the rise in AI-driven engagement. However, the stock plunges nearly 9% in pre-market trading.
QuidelOrtho Q3 Earnings and Revenues Beat Estimates, Margins Expand
QDEL tops Q3 estimates as Labs and Immunohematology units drive growth, while margins strengthen despite respiratory revenue declines.
Inogen Stock Dips Despite Q3 Earnings Beat, Revenues Up Y/Y
INGN stock slid despite a narrower Q3 loss and rising B2B demand, as weaker consumer and rental sales weighed on results.
PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y
PacBio posts a narrower Q3 loss and margin gains, but shares fall as revenues dip amid softer instrument demand.
CONMED Q3 Earnings and Revenues Beat Estimates, Margins Contract
CNMD beats third-quarter 2025 estimates on strength in surgery segments, but gross and operating margins see sharp contraction.
BD Stock Slips in Pre-Market Despite Q4 Earnings Beat, Margins Up
BDX tops fourth-quarter fiscal 2025 earnings estimates and posts strong margin gains, with growth across all business segments and geographies.
Earnings Estimates Rising for Exact Sciences ( EXAS ) : Will It Gain?
Exact Sciences (EXAS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Hims & Hers Stock Slips Post Y/Y Q3 Earnings Decline, Margins Contract
HIMS reports lower third-quarter 2025 earnings even as revenue and subscriber growth remain strong across its channels.
MASI Stock Gains Post Q3 Earnings and Revenue Beat, Margins Expand
Masimo beats third-quarter 2025 earnings and revenue estimates as operating margins and profits improve on lower expenses.
Amicus' Q3 Earnings Beat, Higher Product Sales Drive Y/Y Revenues
FOLD's third-quarter earnings top estimates as rising Galafold and Pombiliti + Opfolda sales lift revenues by 19% year over year.
Here's Why Exact Sciences ( EXAS ) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Exact Sciences Stock Blasted Higher on Tuesday
An impressive beat-and-raise third quarter made the company a standout that day.
Exact Sciences ( EXAS ) is an Intriguing Medical Stock to Watch After Q3 Earnings
Recognized as a leader in medical diagnostics, the upside potential for Exact Sciences (EXAS) stock has been lifted by its improved operational and financial performance.
These Analysts Raise Their Forecasts On Exact Sciences Following Better-Than-Expected Q3 Results - Exact Sciences ( NASDAQ:EXAS )
Exact Sciences Corporation ( NASDAQ:EXAS ) reported better-than-expected third-quarter financial results and raised its FY25 sales guidance above estimates on Monday. Exact Sciences reported quarterly earnings of 24 cents per share which beat the analyst consensus estimate of a loss of 7 ...
Amazon To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday - CrowdStrike Holdings ( NASDAQ:CRWD ) , Amazon.com ( NASDAQ:AMZN )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. JP Morgan raised Qorvo, Inc. ( NASDAQ:QRVO ) price target from $92 to $105.
Exact Sciences ( EXAS ) Q3 2025 Earnings Transcript
Image source: The Motley Fool.Monday, Nov. 3, 2025 at 5:00 p.m. ETChief Executive Officer - Kevin T. ConroyContinue reading ...
Exact Sciences ( EXAS ) Q3 Earnings and Revenues Beat Estimates
Exact Sciences (EXAS) delivered earnings and revenue surprises of +84.62% and +4.97%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Exact Sciences Stock Before Nov. 3?
The company's outlook is improving as its innovative ways continue to pay off.
Rigel Gears Up to Report Q3 Earnings: Here's What to Expect
RIGL's rising Tavalisse sales, along with incremental sales from Rezlidhia and Gavreto, could power another earnings beat in the quarter to be reported.
Coupang Set to Report Q3 Earnings: What's in Store for the Stock?
CPNG sees momentum in Taiwan and logistics ahead of Q3 results, while investments may weigh on margins.
Rigel Gears Up to Report Q3 Earnings: Here's What to Expect
RIGL's rising Tavalisse sales, along with incremental sales from Rezlidhia and Gavreto, could power another earnings beat in the quarter to be reported.
Coupang Set to Report Q3 Earnings: What's in Store for the Stock?
CPNG sees momentum in Taiwan and logistics ahead of Q3 results, while investments may weigh on margins.
Arcutis Biotherapeutics, Inc. ( ARQT ) Hits Fresh High: Is There Still Room to Run?
Arcutis Biotherapeutics (ARQT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zoetis Gears Up to Report Q3 Earnings: Here's What to Expect
ZTS is poised for another earnings beat as rising demand for companion animal products like Simparica Trio and Apoquel drives expected Q3 revenue growth.
TEM vs. EXAS: Which Genomics Player Offers Greater Upside?
Tempus AI's soaring genomics revenues and Exact Sciences' diagnostic breakthroughs spotlight two distinct routes to precision oncology growth.
Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?
Strong Trikafta/Kaftrio demand, along with contributions from Alyftrek, Casgevy and Journavx, may have helped VRTX outperform in the third quarter.
Exelixis ( EXEL ) Reports Next Week: Wall Street Expects Earnings Growth
Exelixis (EXEL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Avidity Biosciences ( RNA ) Moves 42.4% Higher: Will This Strength Last?
Avidity Biosciences (RNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ANI Pharmaceuticals to Report Q3 Earnings: Is a Beat in the Cards?
ANIP's rising Cortrophin Gel sales and new rare disease products, along with generic and other segments, could power another earnings beat this quarter.
